BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 16301355)

  • 1. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Stenestrand U; Lindbäck J; Wallentin L;
    Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
    Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital therapy traditions influence long-term survival in patients with acute myocardial infarction.
    Stenestrand U; Lindbäck J; Wallentin L
    Am Heart J; 2005 Jan; 149(1):82-90. PubMed ID: 15660038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up.
    Berton G; Cordiano R; Cucchini F; Cavuto F; Pellegrinet M; Palatini P
    Int J Clin Pract; 2009 May; 63(5):712-21. PubMed ID: 19392921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
    J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
    Tangelder MJ; Frison L; Weaver D; Wilcox RG; Bylock A; Emanuelsson H; Held P; Oldgren J
    Am Heart J; 2008 Feb; 155(2):382-7. PubMed ID: 18215612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
    Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
    Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block.
    Stenestrand U; Tabrizi F; Lindbäck J; Englund A; Rosenqvist M; Wallentin L
    Circulation; 2004 Oct; 110(14):1896-902. PubMed ID: 15451802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort.
    Stenestrand U; Wallentin L;
    Arch Intern Med; 2003 Apr; 163(8):965-71. PubMed ID: 12719207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction.
    Pedersen OD; Abildstrøm SZ; Ottesen MM; Rask-Madsen C; Bagger H; Køber L; Torp-Pedersen C;
    Eur Heart J; 2006 Feb; 27(3):290-5. PubMed ID: 16267070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
    Friberg L; Hammar N; Rosenqvist M
    Heart; 2010 Feb; 96(4):275-80. PubMed ID: 19710030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA).
    Norhammar A; Stenestrand U; Lindbäck J; Wallentin L;
    Heart; 2008 Dec; 94(12):1565-70. PubMed ID: 18450842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adequacy of anticoagulant prevention in patients with atrial fibrillation].
    García-García J; Calleja-Puerta S; de la Vega-Cerezales V; Benavente-Fernández L; Rodríguez-Rodríguez S; Hernández-Lahoz C
    Rev Neurol; 2005 Oct 1-15; 41(7):399-403. PubMed ID: 16193445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auditing patient registration in the Swedish quality register for acute coronary syndrome.
    Rosvall M; Ohlsson H; Hansen O; Chaix B; Merlo J
    Scand J Public Health; 2010 Jul; 38(5):533-40. PubMed ID: 20406796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Björck L; Wallentin L; Stenestrand U; Lappas G; Rosengren A
    Arch Intern Med; 2010 Aug; 170(15):1375-81. PubMed ID: 20696964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic position and secondary preventive therapy after an AMI.
    Ohlsson H; Rosvall M; Hansen O; Chaix B; Merlo J
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):358-66. PubMed ID: 20087850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.